Attached files
| file | filename |
|---|---|
| 10-K - 2017 10-K - FIBROGEN INC | fgen-10k_20171231.htm |
| EX-32.1 - EX-32.1 - FIBROGEN INC | fgen-ex321_7.htm |
| EX-31.2 - EX-31.2 - FIBROGEN INC | fgen-ex312_10.htm |
| EX-31.1 - EX-31.1 - FIBROGEN INC | fgen-ex311_6.htm |
| EX-10.26 XXXV - EX-10.26 XXXV - FIBROGEN INC | fgen-ex1026xxxv_390.htm |
| EX-10.26 XXXIV - EX-10.26 XXXIV - FIBROGEN INC | fgen-ex1026xxxiv_389.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-216368) and Form S-8 (No. 333-200348, No. 333-213816 and No. 333-216369) of FibroGen, Inc. of our report dated February 27, 2018 relating to the consolidated financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
February 27, 2018